Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment by unknown
PHENOTYPIC  CHARACTERIZATION  AND 
ONTOGENY  OF  MESODERMAL-DERIVED  AND  ENDOCRINE 
EPITHELIAL  COMPONENTS  OF  THE  HUMAN 
THYMIC  MICROENVIRONMENT 
BY  BARTON  F.  HAYNES,  RICHARD M.  SCEARCE,  DAVID F.  LOBACH,  AND 
LUCINDA L.  HENSLEY 
From the Department of Medicine, Division of Rheumatic and Genetic Disease, and the 
Department of Microbiology and Immunology, Duke University School of Medicine, 
Durham, North Carolina 27710 
The thymic microenvironment is a complex specialized tissue derived from at 
least three sources: endoderm of the third pharyngeal pouch, ectoderm derived 
from  the  third  brachial  cleft,  and  mesenchymal stromal  cells  derived  from 
embryonic mesoderm  (1-6).  Pharyngeal pouch endoderm and  brachial  cleft 
ectoderm give rise to epithelial components, while mesodermal-derived mesen- 
chymal cells form the thymic capsule, vessels, and interlobular septae (1-6). Early 
in thymic ontogeny, mesodermal-derived connective tissue induces epithelial cell 
maturation and fetal thymic Iobulation (3, 4). Ultrastructurally, the nonlymphoid 
postnatal thymic microenvironment is composed of macrophages (7), fibroblasts, 
and dark and pale epithelial reticular cells (7,  8).  In postnatal human thymic 
medulla, Hassall's bodies, or keratinized epithelial swirls, are frequently present 
(7, 8). 
Microscopists have long appreciated the dendritic nature of thymic epithelial 
cells (7, 9). Cortical and medullary epithelial cells have long, thin processes that 
connect with other epithelial cells via desmosomes, and form a complex inter- 
digitating meshwork filled with thymocytes (7, 9). Some thymic epithelial cells 
have been  shown to express class  I  and  II  major histocompatibility complex 
(MHC) ~  antigens (10-12), and functional data have demonstrated that the thymic 
microenvironment is responsible for conferring to developing thymocytes the 
ability to recognize self-class I and I I  MHC antigens (13-17).  Kruisbeek et al. 
(18) have recently suggested that during early T  cell development, education of 
class I  MHC-restricted T  cells is conferred by different thymic elements than 
those involved in the education of class II MHC-restricted T  cells. Moreover, a 
subset of epithelial cells within the thymic microenvironment contains a variety 
This work  was supported by grants CA28936,  CA11265,  K0400695,  and AI1-19368 from  the 
National Institutes of Health, and by a Basic Research Grant from the March of Dimes Foundation. 
Address reprint requests to B. F. Haynes, Box 3258, Duke University School of Medicine, Durham, 
NC 27710. 
t Abbreviations used in this paper:  F/P, fluorescein to protein ratio; HB, Hassall's bodies; HTLV, 
human T cell leukemia/lymphoma  virus; MHC, major histocompatibility complex; RITC, rhodamine 
isothiocyanate. 
J. ExP. MED. © The Rockefeller University Press • 0022-1007/84/04/1149/20 $1.00  1 149 
Volume 159  April 1984  1149-1168 1150  HUMAN  THYMIC  MICROENVIRONMENT 
of thymic  hormones  that  are  postulated  to  induce  certain  stages  of T  cell 
maturation (19-22). However, in spite of the important role the thymic microen- 
vironment plays in the maturation of T  cells, little is known regarding antigeni- 
cally definable subsets of cells within the human thymic microenvironment. 
Recently (21,  23) we have described complex ganglioside antigens on human 
and rodent endocrine thymic epithelium, and demonstrated that these thymo- 
poietin- and  thymosin oq-containing epithelial  cells are present  in  two distinct 
regions of the thymus: the subcapsular cortex and medulla. In the present study, 
we use novel monoclonal antibodies raised against human thymic stroma, TE-4 
and TE-7,  to define two mutually exclusive thymic microenvironment compo- 
nents. The TE-4 + epithelial component contains thymosin a~ and keratin, and 
strongly expresses class I HLA-A, -B, and -C (or HLA) and class II Ia-like (or Ia) 
MHC antigens. In contrast, antibody TE-7 defines the mesodermal component 
of the thymic microenvironment that does not contain thymosin a~ or keratin, 
weakly expresses HLA antigens, and does not express Ia antigens. Thus, TE-4 + 
thymic epithelium constitutes an HLA  +, Ia  + endocrine subset of thymic epithelial 
cells and is a prime candidate for a cell type of the human thymic microenviron- 
ment  that  might  participate  in  conferring  MHC  restriction  to  maturing  T 
lymphocytes.  TE-7 +  stroma  most  likely  represents  the  mesodermal-derived 
thymic component that early in development induces thymic epithelial differen- 
tiation. 
Materials and Methods 
Production and Characterization of  Monodonal  Antibodies TE-4 and TE-7.  Antibodies TE- 
4 and TE-7 were the products of a lymphocyte  hybrid fusion between P3X63/Ag8 murine 
myeloma cells (TE-4) or 653 murine myeloma cells (TE-7) and BALB/c spleen cells from 
an animal immunized with fresh human thymic stroma. Murine hybridomas were fused, 
selected, and cloned as previously described (24, 25). Human thymus was obtained from 
either three normal subjects (all less than 16 yr old) at the time of corrective cardiovascular 
surgery for congenital heart disease or from three patients with myasthenia gravis at the 
time of therapeutic thymectomy (age range,  17-31  yr). Thymocytes were gently teased 
from  10-mm~pieces of stroma by mechanical dissociation, the stroma cut into <l-mm 
pieces with scissors and drawn into a  1-cc syringe in RPMI 1640 media (Gibco Laborato- 
ries, Grand Island, NY) through a 19 gauge needle. Female BALB/c mice were immunized 
intraperitoneally with 0.5 cc of stroma on days 0, 7,  14, and 21. On day 24, the spleen 
was removed and a single-cell suspension was obtained. Fusion was performed in 0.8 ml 
of 50% polyethylene glycol 1000 (J. T. Baker Chemical Co., Phiilipsburg, NJ) (24,  25). 
Normal nonimmunized BALB/c spleen cells were added to the fused cell suspension 
(5,000 ceils/well) as feeder cells. To each well of a Linbro flat-bottomed microtiter plate 
(Flow Laboratories, McLean, VA), 0.25 ml of the fused cell suspension was added. After 
8-10 d, the supernatant of visible colonies was removed and assayed for reactivity with 
thymic microenvironment components by indirect immunofluorescence on 4-#m acetone- 
fixed frozen human thymus tissue sections as previously described (26). 
In the TE-4 fusion, 418 wells were seeded, from which 180 colonies were assayed (43% 
fusion efficiency). 20 of 180 screened colonies were positive  in indirect immunofluores- 
cence for reactivity with human thymic tissue sections,  from which hybridoma TE-4 was 
selected and serially passed.  In the TE-7 fusion, 418 wells were seeded from which 121 
colonies were assayed (29% fusion efficiency). 69 of 121  screened colonies were positive 
for reactivity with human thymus sections, from which hybridoma TE-7 was selected and 
serially passed. TE-4 and TE-7 hybridoma cell lines were cloned by limiting dilution until 
all clones assayed were positive;  select positive clones were sequentially passed as mouse 
ascites  tumors. Immunoglobulin isotyping was performed by Ouchterlony gel analysis. HAYNES ET AL.  I 151 
After all clones were positive, they were subcloned three additional times; antibody TE-7 
was shown to be IgG~ and antibody TE-4 was shown to be IgM. 
Other Monoclonal and Polydonal Antisera.  Monoclonai antibody A2B5 was raised against 
chick retinal cells (27) and binds to complex GQ gangliosides on a variety of human and 
rodent neuroendocrine tissues (28, 29). In human thymus, A2B5 defines the endocrine 
component of thymic epithelium (21, 23). Monoclonal antibody 12/1-2 (anti-pl 9) reacts 
with the  19,000 dalton internal core protein (p19) of human T  cell leukemia-lymphoma 
virus (HTLV) and was the generous gift of Dr. M. Robert-Guroff, National Institutes of 
Health (30).  Moreover, anti-pl9 also defines an antigen acquired during ontogeny on 
normal,  A2B5 ÷,  non-HTLV-infected human  thymic epithelium  (31).  Antibody  3F10 
defines a  nonpolymorphic antigen on the HLA-A and -B backbone molecule (32) and 
antibody L243 (American Type Tissue Collection, Rockville, MD)  defines a  nonpoly- 
morphic antigen on the human Ia-like backbone molecule (33). Monoclonal antibody AE- 
1 binds to human keratin and was the generous gift of Dr. Tung Tien Sun, New York 
University School of Medicine,  New  York  (34).  Monospecific rabbit  polyclonal anti- 
thymosin a, antiserum was the generous gift of Dr. Allan Goldstein, George Washington 
University, Washington, DC, and was absorbed for specificity as previously described (23). 
Indirect Immunofluorescence Assays.  Human  thymus  tissue  was  obtained  from  eight 
normal subjects (age 3 mo to 16 yr) at the time of corrective cardiovascular surgery for 
congenital heart disease. Staining of 4-#m acetone-fixed tissue sections with monoclonal 
antibodies in indirect and direct immunofluorescence was performed as previously de- 
scribed in detail (26). Each single or double immunofluorescence assay was performed on 
at least three thymuses. 
Monoclonal antibodies TE-4, TE-7, 3F10, and L243 were directly fluoresceinated as 
previously described (35).  Briefly, fluorescein isothiocyanate (Research Organics,  Inc., 
Cleveland, OH) (50 ug/mg of antibody) was added to ammonium sulfate-purified mono- 
clonal antibody (1 mg/ml in 0.1  M borate buffer in 0.85% saline, pH 9.2), incubated 2 h 
at 37°C, and dialyzed against phosphate-buffered saline. Fluorescence to protein (F/P) 
ratios of the monoclonal antibodies and their saturating titers in direct immunofluores- 
cence were as follows:  P3 (control IgG, myeloma protein), 7.7; 3F10, 3.6 (1:50); L-243, 
4.6 (1:20); TE-4, 9.0 (1:50); and TE-7, 3.3 (1:1,000). Double indirect immunofluorescence 
simultaneously comparing the reactivity of TE-4 or TE-7 with A2B5, L243, 3F10, AE-1 
(antikeratin), TE-4, or TE-7 on thymus tissue was performed as follows:  Unconjugated 
antibody A  was  incubated with  thymus sections and the  sections washed, followed by 
incubation with goat anti-mouse IgG conjugated with rhodamine isothiocyanate (RITC) 
(1:50;  TAGO,  Inc.,  Burlingame,  CA).  After a  second  washing,  the  slides  were  then 
incubated with directly fluoresceinated antibody B, washed, and then viewed for green 
fluorescence using filters for fluorescein excitation (515W, B Nikon) or for red fluores- 
cence  using  filters  for  rhodamine  excitation  (580W,  G  Nikon).  Controls  for double 
immunofluorescence with two murine monoclonai antibodies included thymus sections 
sequentially incubated with (a) P3X63/Ag8 IgG1 parent myeloma protein, RITC-conju- 
gated goat anti-mouse IgG, directly fluoresceinated antibody B, or directly fluoresceinated 
P3X63/Ag8 parent myeloma protein, and (b) antibody A, RITC-conjugated goat anti- 
mouse IgG, followed by directly fluoresceinated P3X63/Ag8  parent myeloma protein. 
Double  indirect immunofluorescence assays  with  rabbit  antithymosin  a~  antisera  and 
monoclonal antibodies TE-4 and TE-7 were performed as previously described in detail 
(21, 23). 
Results 
Reactivity  Patterns of Antibodies  TE-4 and TE-7 on Normal Thymic  Tissue.  TE-4 
reacted with normal thymus in a pattern similar to that described for monoclonal 
antibody  A2B5  (21)  and,  regarding  thymus  >36  mo  postnatal,  anti-pl9  (31). 
Epithelial  reticular cells in  the subcapsular  cortex and  medullary areas of the 
thymus were TE-4  + (Fig.  1 A and B). TE-4  ÷ cells in the medulla went up to and 
surrounded  Hassall's  bodies (HB), while  HB themselves were nonreactive with FIGURE  1.  Reactivity pattern  of antibodies TE-4  and  TE-7  with  normal  human  thymus. 
Using indirect immunofluorescence, TE-4 reacted (A) with normal thymus from a  3-too-old 
subject in a dendritic pattern (arrow) in the subcapsular cortex (S) and medulla (M). Epithelial 
cells in the cortex were predominantly TE-4- (C). The fibrous capsule (above the subcapsular 
cortex) and the interlobular septae were TE-4-.  TE-4 ÷ epithelial cells (arrow) in the thymic 
medulla (B) went up to and surrounded HB (H). The center of HB themselves were TE-4-. 
(C) TE-7 ÷ fibrous interlobular septum (F) between two thymic lobules. Antibody TE-7 did not 
react with epithelium in the subcapsular cortex (S),  cortex (C),  or medulla (not shown), but 
rather reacted with the thymic capsule (arrows) and the fibrous tissue and vessels in interlobular 
septae (F).  ×  400. 
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FIGURE 2.  Direct comparison  of reactivity of directly fluoresceinated TE-7 and  indirectly 
rhodaminated TE-4. (A) TE-4  + dendritic cells in normal 3-too-old thymic medulla (solid small 
arrows) and TE-4- adjacent stroma (large arrow). (B) TE-7  + adjacent stroma (large arrow) with 
TE-4  +,  TE-7-  cells  (solid  small  arrows).  Although  TE-4  + and  TE-7  + cells  were  mutually 
exclusive, it was  seen that  TE-4  + epithelial cells and TE-7  ÷ stromal cells were frequently in 
close physical contact (small open arrows, A and B). x  400. 
TE-4 (Fig.  1B).  Fibrous stroma,  thymic capsule, and interlobular septae did not 
react  with  TE-4.  In  contrast,  antibody  TE-7  reacted  with all  structures  within 
the interlobular septae, with the thymic capsule, and with coarse bands of stroma 
penetrating  into  the cortex  and  medulla  (Fig.  1 C).  To  determine  the  surface 
reactivity of TE-4 and TE-7  with thymocytes in suspension  and also with viable 1154  HUMAN  THYMIC  MICROENVIRONMENT 
FIGURE 3.  TE-4  + epithelial cells contain thymosin a~ while TE-7 stromal cells do not. TE-4 
or TE-7 was sequentially incubated with rabbit anti-thymosin a,  on normal 3-too-old thymus 
sections in double immunofluorescence assay (see Materials and Methods). While TE-4  + thymic 
epithelial cells were uniformly anti-thymosin a~+ (,4 and B, arrows), TE-7 + cells were thymosin 
a~- (C and D). HB (H) stained strongly with anti-thymosin a2  (B) while only the outermost 
layer of epithelial cells surrounding HB were TE-4  + (,4). x  400. 
thymic  stromal  cells,  thymocytes were  teased  from  stroma  and  assayed  for 
reactivity with TE-4 and TE-7 in indirect immunofluorescence and analysis on 
an  Ortho  50H  cytofluorograph (Ortho  Diagnostic  Systems,  Inc.,  Westwood, 
MA). In each of three normal thymocyte suspensions tested, neither TE-4 nor HAYNES  ET  AL.  1155 
TE-7 reacted with viable thymocytes. Similarly, viable thymic stromal tissue was 
minced and  stained  in  suspension  with  TE-4 or TE-7 and assayed for surface 
fluorescence  using  indirect  immunofluorescence  by  placing  stained  (1  mm ~) 
pieces  of  stroma  in  glycerol  under  coverslips  and  viewing  with  fluorescent 
microscopy. We found in three separate experiments that both TE-4 and TE-7 
antibodies reacted with viable thymic stroma cells, indicating  surface reactivity 
of antibodies TE-4 and TE-7. 
Next, in double fluorescence studies using directly fluoresceinated TE-7 with 
TE-4,  we found  that  the  TE-4 ÷ and  TE-7 ÷ stromal  elements  in  thymus  were 
mutually exclusive components of the  thymic  microenvironment  (Fig.  2A and 
B). It was observed, however, that TE-4 ÷ and TE-7 ÷ stromal cells were frequently 
in close contact (small open arrows, Fig. 2A and B). 
Relationship of  Expression of TE-4 and TE- 7 Antigens to Reactivity with Anti- Thymosin 
a~, A2B5, Anti-pl9 and AE-1  (Antikeratin).  TE-4 or TE-7 antibody was sequen- 
tially  incubated  with  rabbit  anti-thymosin  al  on  normal  thymus sections  in  a 
double  immunofluorescence  assay.  While  TE-4 ÷  thymic  epithelial  cells  were 
uniformly thymosin oq ÷ (Fig.  3A and B), TE-7 ÷ cells were uniformly thymosin 
a~-  (Fig.  3C and D).  Interestingly,  HB stained  strongly with anti-thymosin  al 
(Fig. 3B) while only the outermost layer of epithelial cells surrounding HB were 
TE-4 ÷ (Fig.  1B, 3A and B). 
We have previously shown (21,  31) antibodies A2B5 and anti-HTLV p19 to 
be markers of endocrine (thymosin al-containing) thymic epithelium. Therefore, 
we investigated  the  reactivity of A2B5  or anti-pl9  with  either  TE-4  or TE-7 
antibodies in  double immunofluorescence  experiments.  As expected from the 
pattern  of anti-thymosin  a~ reactivity with TE-4 + and TE-7 + stroma, we found 
that  TE-4 ÷ cells were A2B5 +, p19 ÷, while TE-7 + cells were A2B5-, p19-  (not 
shown).  In  double  immunofluorescence  assays  comparing  AE-1  (antikeratin) 
reactivity and  TE-4  or TE-7,  we found that  TE-4 ÷ cells were AE-1 ÷, whereas 
TE-7 + cells were uniformly AE-1- (not shown). Whereas AE-1  reacted strongly 
with HB, TE-4 did not. 
Expression of MHC Antigens by Endocrine Thymic Epithelium (TE-4 +) and Nonen- 
docrine Thymic Stroma (TE-7+).  To determine the  MHC antigens  expressed by 
TE-4 + or TE-7 ÷ thymic stroma cells, either directly fluoresceinated anti-HLA- 
A, -B, and -C monoclonal  antibody (3F10) or anti-Ia  monoclonal  antibody (L- 
243)  was sequentially  incubated  on  thymus  sections that  had  been  previously 
labeled with either TE-4 or TE-7 antibodies and rhodaminated goat anti-mouse 
Ig.  In  these  double-labeling experiments,  we found  TE-4 ÷ thymic  epithelium 
strongly  expressed  HLA and  Ia  antigen  (Fig.  4A-D).  While  more  cells  were 
HLA  + and Ia  + than were TE-4 +, all TE-4 + cells were clearly HLA  ÷ and Ia ÷. In 
contrast,  TE-7 + thymic stroma was uniformly Ia-. Areas of TE-7 + stroma were 
also HLA unreactive,  while  foci of TE-7 + thymic  stroma  reacted  weakly with 
anti-HLA antibody (Figs.  4E-H).  Table I summarizes the phenotype of TE-4 ÷ 
and TE-7 + human thymic microenvironment components. 
Tissue Distribution of TE-4 and TE-7 Reactivity.  Reactivity of TE-4 and  TE-7 
antibodies with a variety of normal tissues and cell types was determined  using 
indirect immunofluorescence (Table II). TE-4 reacted only with the endocrine 
thymic epithelium and, interestingly, with the basal layer of squamous epithelium 1156  HUMAN  THYMIC  MICROENVIRONMENT 
FIGURE 4.  Expression of MHC antigens by endocrine thymic epithelium (TE-4  +) and thymic 
stroma (TE-7÷).  Either directly fluoresceinated anti-HLA (3F10)  or anti-Ia (L-243) was se- 
quentially incubated on normal 3-mo-old thymus sections previously labeled with either TE-4 
or TE-7 and rhodaminated goat antimouse Ig. TE-4 + epithelium (A and C, arrows) strongly 
expressed HLA antigens (B, arrows) and Ia antigens (D, arrows).  In C and D,  it is easiest to 
compare reactivity of TE-4 and anti-la antibody around HB. As TE-4 ÷ epithelial cells flatten 
to form the concentric layer of cells within HB, the simultaneous expression of TE-4 and Ia 
can be seen (large and small arrows). The TE-7 ÷ stroma (E and G, arrows) was either weakly 
HLA + or HLA- (F, arrow) while all TE-7 ÷ stroma was la- (H, arrow), x  400. HAYNES  ET  AL.  1 157 
TABLE  I 
Characteristics of TE-4 ÷ and TE-7 ÷ Components of  Human Thymic Microenvironment 
TE-4  TE-7 
Localized in subcapsular cortex and medulla  Yes  No 
Localized in thymic capsule, interlobular septae  No  Yes 
Contained thymosin a~  Yes  No 
Reactivity with: 
Anti-HLA (3F10)  Positive  Weakly positive to negative 
Anti-Ia (L-243)  Positive  Negative 
A2B5  Positive  Negative 
Anti-p  19  Positive  Negative 
Antikeratin (AE- 1)  Positive  Negative 
TABLE  II 
Reactivity Patterns of TE-4 and TE-7 Monoclonal Antibodies with Normal Tissues* 
Tissue 
Antibodies 
TE-4  TE-7 
Thymus*  Endocrine thymic  Non-endocrine thymic 
Epithelium  stroma and vessels 
Spleen  Negative  Fibrous stroma and vessels 
Tonsil  Basal layer of squamous epithelium  Fibrous stroma and vessels 
Lymph node  Negative  Fibrous stroma and vessels 
Skin  Basal layer of squamous epithelium  Fibrous stroma and vessels 
Esophagus  Basal layer of squamous epithelium  Fibrous stroma and vessels 
Liver  Negative  Fibrous stroma and vessels 
Kidney  Negative  Fibrous strOma and vessels 
Brain (cortex)  Negative  Fibrous stroma and vessels 
Brain (medulla oblongata)  Negative  Fibrous stroma and vessels 
Pancreas  Negative  Fibrous stroma and vessels 
Adrenal  Negative  Fibrous stroma and vessels 
Thyroid  Negative  Fibrous stroma and vessels 
Pituitary  Negative  Fibrous stroma and vessels 
Conjunctiva  Basal layer of squamous epithelium  Fibrous stroma and vessels 
Appendix  Negative  Fibrous stroma and vessels 
* Reactivity of monoclonal antibodies was determined by indirect immunofluorescence on acetone- 
fixed frozen tissue sections. 
* In addition to assay on frozen tissue sections, reactivity of TE-4 and TE-7 with peripheral blood 
mononuclear cells (three subjects), thymocytes (three subjects), and tonsillar lymphocytes in suspen- 
sion (two subjects)  were assayed by indirect fluorescence, analyzed on an Ortho 50H cytofluoro- 
graph and  found  to be TE-4- and  TE-7- in all cases.  Reactivity of TE-4  and TE-7  was also 
determined on human foreskin fibroblast lines. Fibroblasts growing in culture were strongly TE- 
7  + with both surface and intracytoplasmic reactivity; human foreskin fibroblasts did not react with 
antibody TE-4. 
in skin (Fig. 5A), esophagus, tonsil (Fig. 5B), and conjunctiva. In tonsil, the TE- 
4 +  epithelial  layer  at  the  base  of tonsillar crypts  splayed  out  into  a  dendritic 
pattern (not shown).  Unlike antibody A2B5, which reacted with most endocrine 
cell  types  (28,  29),  antibody  TE-4  did  not  react  with  islet  cells  of pancreas, 
anterior pituitary, or adrenal  medulla (Table II).  In contrast to TE-4, antibody 1158  HUMAN  THYMIC  MICROENV1RONMENT 
FIGURE 5.  Reactivity of antibody TE-4  with extrathymic epithelial cells.  Antibody TE-4 
reacted with the basal layer of tonsillar (A, arrow) and skin (B, arrow) epithelium. Suprabasilar 
epithelial cells were faintly TE-4  + while stratum granulosum and stratum corneum were TE- 
4- (not shown). × 400. 
TABLE  III 
Reactivity of TE-4 and TE-7 Monoclonal Antibodies with Fresh 
Malignant Tumor Cells and Malignant Cell Lines* 
Tumor (No. of samples tested) 
Antibody 
TE-4  TE-7* 
Fresh tissue 
Melanoma in skin (1) 
Cutaneous T  cell lymphoma in skin (3) 
T  cell lymphoma of ileum (1) 
Peripheral blood T  cell acute lympho- 
blastic leukemia cells (1) 
Breast carcinoma (3) 
Lung squamous cell carcinoma (1) 
Fibrosarcoma in skin (1) 
Ovary adenocarcinoma (1) 
Prostate adenocarcino.ma (1) 
Prostate adenocarcinoma (3) 
Thymoma (4) 
Negative  Negative 
Negative  Negative 
Negative  Negative 
Negative  Negative 
Negative  Negative 
Negative  Negative 
Negative  Positive 
Negative  Negative 
Positive  Negative 
Negative  Negative 
Positive  See Text 
Cell lines 
4475-Breast adenocarcinoma 
5577-Lung carcinoma 
HUT 102 HTLV  + cutaneous T cell lym- 
phoma cell line 
Negative  Negative 
Negative  Negative 
Negative  Negative 
* Reactivity of monoclonal antibodies was determined by indirect immu- 
nofluorescence on acetone-fixed frozen tissue sections or on cytocentri- 
fuge preparations of cell suspensions. 
* While TE-7 reactivity was uniformly negative on tumor cells in all tissues 
except fibrosarcoma, TE-7 reacted with the nonmalignant supporting 
stroma in all tissues tested. 
TE-7  was  not  tissue  specific,  since  TE-7  reacted  with  fibrous  stroma  in  every 
tissue tested (Table II). 
Next, reactivity of TE-4 and TE-7 monoclonal antibodies with malignant cells 
was tested (Table III). TE-4 was nonreactive with carcinomas of lung and breast, 
but was reactive with  1 of 4  adenocarcinomas  of prostate tested. All other tumor HAYNES ET  AL.  1 159 
FIGURE 6.  Human  7-wk fetal thymus. This transverse section through the upper thorax of 
a 17-mm fetus shows the esophagus (E), trachea (T), and the left lateral thymic rudiment 
(arrows) (hematoxylin and eosin stain), x 100. 
types tested were TE-4 nonreactive except thymomas, which contained strands 
of TE-4  ÷ epithelial cells uniformly distributed throughout lymphoid areas. 
The  only malignant  cells that  were TE-7 ÷ were in skin  fibrosarcoma (Table 
III).  TE-7 ÷  stroma  was  present  throughout  thymoma  tissue.  Given  that  the 
malignant  cell type in thymomas is not clearly understood,  we could not assess 
whether the thymoma TE-7 ÷ stroma was benign or malignant.  Phylogenetically, 
TE-4 and TE-7 were not reactive with rat, rabbit, and mouse thymus. 
Thus,  the  antigen  defined  by antibody  TE-7  appears  to  be  a  marker  for 
mesodermally derived (mesenchymal)  human  connective tissue and  tumors de- 
rived from such tissue (e.g., fibrosarcomas).  In contrast, antibody TE-4 defines 
A2B5  +, p19  ÷, thymic epithelial cells that contain  thymic hormones and keratin 
and are physically located in the thymic subcapsular cortex and medulla.  Unlike 
antibody A2B5,  antibody TE-4  is  specific for thymic  epithelial  cells,  with  the 
exception of TE-4 expression on the basal cell layer of squamous epithelium and 
on rare  tumors of epithelial  origin  (prostate).  Unlike antikeratin  (AE-1),  TE-4 
did not bind to HB. 
Ontogeny Study of TE-4  and  TE-7  Components of Human  Thymus Microenviron- 
ment.  During morphogenesis of the human thymus gland,  the fibrous capsule, 
stroma, and vessels are derived from mesodermal or mesectodermal (mesenchy- 
mal) tissue (3, 4, 36). The cortical epithelial component of the thymic microen- 
vironment is thought to be derived from the ectodermal brachial cleft, while the 
medullary epithelium is thought to be derived from the third pharyngeal pouch 
endoderm (1,  2,  5,  6). Auerbach (3,  4) has demonstrated  that the mesodermal >
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FIGURE 8.  Human 12-wk fetal thymus. (A) TE-4  + epithelium in a dendritic pattern (arrows) 
in the  12-wk fetal thymus, which is now populated with E-rosette  +, 3A1  + thymocytes (T cell 
markers not shown). (B) TE-7  + fibrous capsule, vessels (V), and interlobular septum (arrows) 
in the lobulated 12 wk fetal thymus. X 400. 
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FIGURE 9.  Acquisition  of human thymic epithelial antigens  during ontogeny. Whereas A2B5, 
TE-4, and TE-7 antigens  were preserved throughout ontogeny, the p19 antigen was selectively 
acquired during ontogeny (31). 1162  HUMAN  THYMIC  MICROENVIRONMENT 
component of the thymus microenvironment (fibroblasts and vessels) surrounds 
the thymic primordia in the human at 6-7  wk gestation (3, 4).  Thus, from the 
characterization  of the  reactivity  of TE-4,  TE-7,  A2B5,  and  p19  monoclonal 
antibodies,  we  expected  TE-7  to  identify  the  outer  mesenchymal  connective 
tissue of the preseptated  thymic primordia (7-9  wk gestation), and to identify 
interlobular septai tissue,  vessels, and thymic capsule of lobulated fetal thymus 
(10-12 wk gestation). In contrast, TE-4 and A2B5, if conserved during ontogeny, 
should be present on epithelial components of thymic epithelium. 
An ontogeny study of the reactivity of antibodies A2B5, p19, TE-4, and TE- 
7 was performed on seven fetal and five infant thymuses of the following ages: 
Fetal-  7,  9,  10,  13,  15,  16, and  24 wk gestation; postnatal-  3,  6,  12,  36,  and 
481/2 mo. The thorax  of the earliest  fetus available for study (7 wk gestational 
age with a  17-mm crown-rump length) was  serially sectioned (4 #m) from the 
base of the heart through the oral cavity. Hematoxylin and eosin (H and E) stains 
of sections were performed at 80-t~m  intervals. At  7 wk, the thymic rudiments 
were still  paired  tubular  structures  ~160  /~m in  length ventral  to  the carotid 
artery, which had not yet fully migrated caudally and fused at the midline (1, 2, 
6). Thymic epithelial rudiments until the 9th to 11 th wk were devoid of lymphoid 
cells entirely (6, 37).  Fig. 6 demonstrates a  low power view (X  100) of the 7 wk 
thymic rudiment,  Fig.  7A, a  high power (X  200)  view.  In Fig.  7B the A2B5 ÷ 
thymic epithelium is depicted (arrows), while 7 C shows TE-4 ÷ thymic epithelium. 
Fig.  7D shows the outer rim of TE-7 ÷ mesodermally derived connective tissue 
(arrows) surrounding TE-7- epithelial thymus. The entire epithelial thymus at 7 
wk  was  plg-  (not  shown).  From  9  to  13  wk,  TE-4 ÷,  A2B5 ÷ epithelium  was 
arranged  in  lobulated  zones  surrounded  by  TE-7 ÷ areas  with  no  discernable 
cortical-medullary junction  (Fig.  8A  and  B);  no  HB  were  seen.  After  9  wk 
gestational  age,  numerous thymocytes were present  that  expressed  the T  cell 
antigens  35.1  (E-rosette  receptor)  and  3A1  (24,  35).  By  15  wk,  a  cortical- 
medullary junction was present and the TE-4 ÷ component had compartmental- 
ized into the subcapsular cortical and medullary areas.  Furthermore, at  15  wk 
HB were present as seen in normal infant thymuses (not shown). As previously 
described, anti-p 19 defined an antigen on endocrine (TE-4 ÷) epithelium that was 
acquired during ontogeny, first appearing  in  the subcapsular  cortex  region at 
between  12 and  15 wk fetal gestation (31). 
Fig. 9 summarizes the results of the ontogeny study of reactivity of A2B5, TE- 
4,  anti-pig,  and  TE-7  antibodies  with human thymic microenvironment com- 
ponents beginning at  10 wk of fetal gestation. 
Discussion 
Using two novel monoclonal antibodies, TE-4 and TE-7, our study character- 
izes two components of the human thymic microenvironment: the TE-4 + endo- 
crine epithelial cells and TE-7 ÷ nonendocrine fibrous stroma. 
The thymic microenvironment is a  complex epithelial-stromal  compartment 
within  which  thymocytes  mature  and  undergo  a  variety  of  phenotypic  and 
functional changes. Embryonically, data suggest that at least three separate tissues 
come together during fetal development to form the thymic microenviroment. 
Mesodermal cells give rise to fibroblasts and other connective tissue cells. Thymic HAYNES  ET  AL.  1163 
epithelial  cells  have  been  postulated  (1,  2)  to  be  derived  from brachial  cleft 
ectoderm and the third pharyngeal  pouch endoderm.  Moreover,  neural  crest 
ectoderm has also been suggested to contribute to the thymic microenvironment 
(36). 
In both mouse (5) and man (1, 2), it has been shown that the thymus develops 
primarily from the third endodermal pharyngeal pouch and the third ectodermal 
cleft. In man (4-5 wk) and mouse (day 11), proliferation of the ectoderm of the 
third  brachial  cleft  covers  the  endodermally  derived  epithelium  (1-6).  The 
endodermal thymic epithelial component appears to chemically attract immigrant 
blood-borne stem cells (3, 36) that in man first appear in the thymus at weeks 8- 
9  (6,  37).  Thus, the epithelial component of mature (neonatal) normal thymic 
microenvironment is thought to be composed of a  central endodermal region 
and a peripheral ectodermal region (2); cortical epithelial cells are thought to be 
ectodermal in origin while medullary epithelial cells are endodermal in origin 
(2,  5).  Whether  the  TE-4 ÷ population  of subcapsular  cortical  and  medullary 
epithelial cells constitute the endodermal or the ectodermal component ofthymic 
epithelium at present remains speculative. Our ontogeny study did not include 
embryos before 7 wk gestation, necessary to resolve this question. Clearly there 
are cortical epithelial cells that are TE-4-,  HLA ÷, Ia  ÷, and contain keratin (10, 
11). Moreover, we have recently developed a  monoclonal antibody (TE-3) that 
selectively defines the cortical but not medullary component of thymic epithelium 
(E. McFarland, and B. F. Haynes, manuscript submitted). 
The most likely origin for TE-4 + epithelium, based on its physical location in 
thymus (medulla and  subcapsular  cortex)  is pharyngeal  pouch endoderm (2). 
However, the shared expression of TE-4 antigen by thymic epithelial cells with 
cells of known ectodermal origin (basal  layer of squamous epithelium of con- 
junctiva and skin) suggests possible ectodermal origin of TE-4 + thymic epithe- 
lium. 
Regarding the  shared  expression of TE-4  antigen  of thymic epithelial cells 
with basal epithelial cells, it should be noted that each of the markers of endocrine 
thymic epithelium (TE-4,  p19, and A2B5) are expressed on the basal  layer of 
squamous epithelium (21, 23, 31). Whereas A2B5 is also expressed on a variety 
of neuroendocrine tissues,  the basa!  layer of squamous epithelium is the only 
known normal  human tissue other than thymic epithelium that expresses p19 
and TE-4. Interestingly, skin and tonsil epithelium have both been implicated in 
promoting extrathymic T  cell maturation or activation (26, 38-40). Further, the 
basal  layer of keratinocytes in skin have  recently been  shown to contain both 
thymopoietin-like and  thymulin-like  thymotrophic  hormones  (41,  42).  Thus, 
regardless of the endodermal vs. ectodermal origin of TE-4 + thymic epithelium, 
the presence of TE-4, A2B5, and p19 antigens on thymic epithelium and basal 
keratinocytes  of squamous  epithelium  might  signify  common T  cell  trophic 
functions, and identify extrathymic as well as intrathymic T  cell-inductive envi- 
ronments. 
Using the tonofilament stain, tannic acid-phosphomolybdic acid-amido black 
(TPA),  Pereira  and  Clermont  (43)  identified  two components of the  thymic 
microenvironment: TPA + epithelial reticular  cells localized to the subcapsular 
cortex, cortex, and medulla, and TPA- fibrous capsule, interlobular septae, and 1164  HUMAN  THYMIC  MICROENVIRONMENT 
vessels. Most likely, a subset of TPA  + epithelial reticular cells corresponds to TE- 
4 + epithelium, and the TPA- component to TE-7 + stroma. 
Several lines of evidence suggest that TE-4 does not bind to known keratin- 
like molecules. While all TE-4 + cells contain keratin as defined by antibody AE- 
1,  not all  keratinized cortical epithelial cells were TE-4  ÷ nor were AE-1 + HB 
reactive with TE-4. Moreover, TE-4 had surface reactivity with thymic epithelial 
cells, and skin and thymic epithelial cells grown in culture frequently are TE-4- 
and AE-1 ÷ (antikeratin  +) (K. Singer, E. A. Harden and B. F. Haynes, unpublished 
observations).  TE-4,  though  having  a  similar  reactivity  pattern  to  anti-pl9, 
differed from anti-pl9 in that TE-4 was conserved in ontogeny beginning at 7 
wk, and did not react with HTLV-infected T  cells (HUT 102 cells). 
At 5-7  wk gestation,  mesenchymal cells derived from the fetal mesodermal 
germ  layer  form  a  network  of fibroblasts  that  surround  the  human  thymic 
rudiment (2-4).  From 7  to  9  wk gestation,  the surrounding connective tissue 
invaginates the thymus and sends fibrous septae throughout the epithelial rudi- 
ment,  effecting thymic lobulation  (2-4,  36).  Mesoderm-derived mesenchymal 
tissue also gives rise to vessel endothelium, cartilage, and a variety of other tissues 
(6).  While antibody TE-7 in the adult was specific for fibroblasts and vessels in 
all organs tested, it reacted with cartilage, vessels,  and mesenchymal interstitial 
cells in early fetal tissues. Notocord, neural crest ectoderm, spinal cord, and all 
endodermal tissues were TE-7-. Thus, TE-7 identified primarily cells of meso- 
dermal origin in fetal and adult tissues. Regarding the thymus, TE-7 identified 
the mesodermal-derived fibrous septae and vessels.  The results of our ontogeny 
study agreed with light microscopic descriptions of the relationship of fibrous 
(TE-7  ÷) stroma to thymic epithelial rudiments from 7 wk gestation through birth 
(2-4). We further demonstrated the TE-7 antigen to be conserved in ontogeny 
as early as 7 wk gestation. 
In the quail-chick hybrid system, LeDouarin and Jotereau (36) demonstrated 
that mesenchyme from neural crest mesectoderm gave rise to thymic connective 
tissue and vessels.  On the other hand, it has been suggested (44) that the neural 
crest  contribution  to  the  thymus forms  the  endocrine epithelial  component, 
based on the known common function of neuroendocrine secretory cells and on 
the common expression of the complex ganglioside antigen defined by monoclo- 
nal antibody A2B5  on thymic epithelium and neural and neural crest-derived 
human and rodent tissues (21, 27-29).  In the present study, we showed that all 
TE-4  + cells that contained thymosin oq and keratin were A2B5 +. Conversely, all 
TE-7 +  mesenchymal-derived connective  tissue  cells  were  A2B5-.  Thus,  the 
neural crest mesectodermal component of the thymic microenvironment pro- 
posed by LeDourain and Jotereau (36) most likely corresponds conceptually to 
the TE-7 +, TE-4- component of human thymic stroma. The presence of neural 
crest-derived mesenchyme in  human  thymus  tissue,  however,  remains  to  be 
demonstrated. 
In the postnatal thymus, the TE-7 ÷ component of thymic stroma was located 
in  the interlobular  septae and  throughout the cortex and  medulla as fibrous 
bands of Ia-negative and HLA weakly positive connective tissue. The importance 
of TE-7 as an antigenic marker of the mesodermal-derived component of thymic 
stroma  is  indicated by the observations  of Auerbach (3)  and  others (36)  that HAYNES  ET  AL.  1165 
mesodermal stroma  may play  an  important  role  in  inducing  murine  thymic 
epithelial differentiation and fetal thymic iobulation at the stage of fetal devel- 
opment just before lymphoid cell population of the thymic rudiment. 
Thus, the availability of antibodies TE-4 and TE-7 should allow for the physical 
separation and in vitro study of the physiology of the mesodermal and endocrine 
epithelial components of fetal and postnatal  thymic microenvironments. This 
approach should facilitate the study of these human thymic microenvironment 
components in  normal  thymus development and  in  the generation of T  cell 
diversity and MHC restriction. Limited quantities of TE-4 and TE-7 antibodies 
are available to interested investigators upon request. 
Summary 
Using murine monoclonal antibodies TE-4  and TE-7  raised against human 
thymic stroma, we identified two distinct and mutually exclusive thymic microen- 
vironment components: the thymic endocrine epithelium (TE-4  ÷) and mesoder- 
mal-derived fibrous stroma (TE-7+). TE-4-reactive epithelium did not react with 
antibody TE-7, contained thymosin a~ and keratin, and expressed other known 
markers of thymic endocrine epithelium  (A2B5  and  p19).  Moreover,  TE-4 ÷ 
thymic epithelial cells strongly expressed class I (HLA-A, -B and -C) and class II 
(Ia-like) major histocompatibility complex (MHC) antigens. In contrast,  TE-7  + 
thymic fibrous stroma did not react with antibody TE-4, did not contain thymosin 
~  nor keratin, and did not express the thymic endocrine epithelium markers 
A2B5 and p 19. TE-7 ÷ thymic stromal cells weakly expressed class I and did not 
express class II MHC antigens. Both TE-4  ÷ and TE-7 + thymic microenvironment 
compartments were identifiable in  thymus from 7  wk gestation through adult 
life.  At  7  wk  fetal  gestation,  TE-7 ÷ stroma  surrounded a  cylindrical TE-4  +, 
A2B5 + thymic epithelial rudiment. Between 10 and  15 wk fetal gestation, TE- 
7 + thymic stroma surrounded early thymic lobules.  By  15  wk fetal gestation, 
antibody TE-4  defined subcapsular cortical and medullary zones of endocrine 
thymic epithelium, while antibody TE-7  bound to  interlobular fibrous septae, 
vessels, and thymic fibrous capsule. While otherwise specific for endocrine thymic 
epithelium, antibody TE-4 reacted with the basal layer of squamous epithelium 
in skin, tonsil, conjunctiva, and upper esophagus. 
We thank Ms.  Winifred Ho for expert technical assistance and Ms. Joyce Lowery for 
expert secretarial assistance. 
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